Ontology highlight
ABSTRACT:
SUBMITTER: Kindon N
PROVIDER: S-EPMC5601455 | biostudies-literature | 2017 Sep
REPOSITORIES: biostudies-literature
ACS medicinal chemistry letters 20170901 9
<i>N</i>-(5-Bromo-3-methoxypyrazin-2-yl)-5-chlorothiophene-2-sulfonamide <b>1</b> was identified as a hit in a CCR4 receptor antagonist high-throughput screen (HTS) of a subset of the AstraZeneca compound bank. As a hit with a lead-like profile, it was an excellent starting point for a CCR4 receptor antagonist program and enabled the rapid progression through the Lead Identification and Lead Optimization phases resulting in the discovery of two bioavailable CCR4 receptor antagonist candidate dru ...[more]